University of Münster
CRIS@UM
DE | EN

Claudia Janoschka

No current affiliations available for this person. The person is no longer active at the university.

Publications

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023)
In: Therapeutic Advances in Neurological Disorders, 16.
Research article (journal)
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
Fleck AK, Hucke S, Teipel F, Eschborn M, Janoschka C, Liebmann M, Wami H, Korn L, Pickert G, Hartwig M, Wirth T, Herold M, Koch K, Falk-Paulsen M, Dobrindt U, Kovac S, Gross CC, Rosenstiel P, Trautmann M, Wiendl H, Schuppan D, Kuhlmann T, Klotz L (2021)
In: Brain, 144(4).
Research article (journal)
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis
Herich S, Schneider-Hohendorf T, Rohlmann A, Khaleghi Ghadiri M, Schulte-Mecklenbeck A, Zondler L, Janoschka C, Ostkamp P, Richter J, Breuer J, Dimitrov S, Rammensee H, Grauer OM, Klotz L, Gross CC, Stummer W, Missler M, Zarbock A, Vestweber D, Wiendl H, Schwab N (2019)
In: Brain, 142(11).
Research article (journal)
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study
Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L (2018)
In: Frontiers in immunology, 9.
Research article (journal)
Long-term natalizumab treatment enhances the pathogenic signature of Th17 cells - potential implications for treatment cessation?
Janoschka C, Schulte-Mecklenbeck A, Starost L, Schafflick D, Schneider-Hohendorf T, Hoerste GM, Gross CC, Schwab N, Kuhlmann T, Wiendl H, Klotz L (2018)
In: Multiple Sclerosis, 24(2).
Research article (journal)
Show all publications

Projects

KFO 342 - Z: Immune System variables in healthy subjects and during systemic inflammation
Duration: 01/10/2023 - 30/09/2026 | 2nd Funding period
Funded by: DFG - Clinical Research Unit
Type of project: Subproject in DFG-joint project hosted at University of Münster